Neurological manifestations in thrombotic microangiopathy: Imaging features, risk factors and clinical course

被引:9
作者
de Castro, Jose Thiago de Souza [1 ,2 ]
Appenzeller, Simone [3 ]
Colella, Marina Pereira [4 ]
Yamaguti-Hayakawa, Gabriela [4 ]
De Paula, Erich Vinicius [4 ,5 ]
Annichinno-Bizzachi, Joyce [4 ,5 ]
Cendes, Fernando [6 ]
Fabiano, Reis [1 ,2 ]
Orsi, Fernanda Andrade [7 ]
机构
[1] Univ Campinas UNICAMP, Sch Med Sci, Campinas, SP, Brazil
[2] Univ Campinas UNICAMP, Dept Radiol, Campinas, SP, Brazil
[3] Univ Estadual Campinas, Sch Med Sci, Rheumatol Unit, Campinas, SP, Brazil
[4] Univ Campinas UNICAMP, Hematol & Hemotherapy Ctr, Thrombosis & Hemostasis Unit, Campinas, SP, Brazil
[5] Univ Campinas UNICAMP, Sch Med Sci, Dept Internal Med, Discipline Hematol & Hemotherapy, Campinas, SP, Brazil
[6] Univ Estadual Campinas, Sch Med Sci, Dept Neurol, Campinas, SP, Brazil
[7] Univ Campinas UNICAMP, Sch Med Sci, Dept Clin Pathol, Campinas, SP, Brazil
来源
PLOS ONE | 2022年 / 17卷 / 09期
关键词
THROMBOCYTOPENIC PURPURA; TTP; DIAGNOSIS; RECOVERY;
D O I
10.1371/journal.pone.0272290
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background and purposeThrombotic microangiopathy (TMA) is a group of microvascular occlusive disorders that presents with neurological involvement in up to 87% of the cases. Although the central nervous system (CNS) is an important target organ in TMA, the role of neurological manifestations in the disease clinical course is not well established. In this study, we described the neurological manifestations and CNS radiological aspects in patients with a first, acute TMA event. We also examined the association between severe neurological involvement and adverse clinical outcomes in TMA. MethodsA cohort of patients diagnosed with a first TMA event between 1995 and 2016 was included, their medical charts and imaging tests were retrospectively evaluated. ResultsA total of 49 patients were included, 85.7% were women and the mean age was 36.5 years-old (SD 13.0). Neurological manifestations were described in 85.7% of the patients, most of them (88%) were considered severe and consisted of confusion, compromised sensorimotor function, stupor, seizures, and personality change. Imaging tests were performed in 62% of the patients with neurological manifestations and detected acute CNS lesions, such as posterior reversible encephalopathy syndrome, hemorrhagic and ischemic stroke were observed, in 7 (27%) of them. While the need for intensive care unit admission was greater and longer among patients with severe neurological manifestations, the number of plasma exchange sessions, the total duration of hospitalization and in-hospital death were similar between groups. ConclusionsSevere neurological manifestations are common in first TMA events and are responsible for a worse disease presentation at admission. While the effect of neurological manifestations on acute TMA clinical course seems to be modest, these manifestations may have an important impact on the development of chronic cognitive impairment, which highlights the need for proper diagnosis and treatment.
引用
收藏
页数:12
相关论文
共 33 条
  • [1] Acedillo Rey R, 2016, BMJ Case Rep, V2016, DOI 10.1136/bcr-2016-215491
  • [2] Cerebral MRI findings predict the risk of cognitive impairment in thrombotic thrombocytopenic purpura
    Alwan, Ferras
    Mahdi, Dina
    Tayabali, Sarrah
    Cipolotti, Lisa
    Lakey, Grace
    Hyare, Harpreet
    Scully, Marie
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2020, 191 (05) : 868 - 874
  • [3] Thrombotic microangiopathies: a general approach to diagnosis and management
    Arnold, Donald M.
    Patriquin, Christopher J.
    Nazy, Ishac
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2017, 189 (04) : E153 - E159
  • [4] Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study
    Bendapudi, Pavan K.
    Hurwitz, Shelley
    Fry, Ashley
    Marques, Marisa B.
    Waldo, Stephen W.
    Li, Ang
    Sun, Lova
    Upadhyay, Vivek
    Hamdan, Ayad
    Brunner, Andrew M.
    Gansner, John M.
    Viswanathan, Srinivas
    Kaufman, Richard M.
    Uhl, Lynne
    Stowell, Christopher P.
    Dzik, Walter H.
    Makar, Robert S.
    [J]. LANCET HAEMATOLOGY, 2017, 4 (04): : E157 - E164
  • [5] The Differential Diagnosis and Treatment of Thrombotic Microangiopathies
    Bommer, Martin
    Woelfle-Guter, Manuela
    Bohl, Stephan
    Kuchenbauer, Florian
    [J]. DEUTSCHES ARZTEBLATT INTERNATIONAL, 2018, 115 (19): : 327 - +
  • [6] Brain lesions are most often reversible in acute thrombotic thrombocytopenic purpura
    Burrus, Tamika M.
    Wijdicks, Eelco F. M.
    Rabinstein, Alejandro A.
    [J]. NEUROLOGY, 2009, 73 (01) : 66 - 70
  • [7] Atypical hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: Clinically differentiating the thrombotic microangiopathies
    Cataland, Spero R.
    Wu, Haifeng M.
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2013, 24 (06) : 486 - 491
  • [8] Hemolytic Uremic Syndrome
    Cody, Ellen M.
    Dixon, Bradley P.
    [J]. PEDIATRIC CLINICS OF NORTH AMERICA, 2019, 66 (01) : 235 - +
  • [9] Deaths and complications associated with the management of acute immune thrombotic thrombocytopenic purpura
    Colling, Meaghan
    Sun, Lova
    Upadhyay, Vivek
    Ryu, Justine
    Li, Ang
    Uhl, Lynne
    Kaufman, Richard M.
    Stowell, Christopher P.
    Dzik, Walter H.
    Makar, Robert S.
    Bendapudi, Pavan K.
    [J]. TRANSFUSION, 2020, 60 (04) : 841 - 846
  • [10] Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura
    Deford, Cassandra C.
    Reese, Jessica A.
    Schwartz, Lauren H.
    Perdue, Jedidiah J.
    Hovinga, Johanna A. Kremer
    Laemmle, Bernhard
    Terrell, Deirdra R.
    Vesely, Sara K.
    George, James N.
    [J]. BLOOD, 2013, 122 (12) : 2023 - 2029